Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. Class A Common Stock

Liminatus Pharma, Inc. Class A Common Stock

LIMN

Rank in Stocks #32525
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical... Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
Share Price
$2.99
Last synced: 2026-11-13
Market Cap
$1.42M
Change (1 day)
7.94%
Change (1 year)
182.08%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Trade Liminatus Pharma, Inc. Class A Common Stock (LIMN)

Category

Healthcare
EPS for Liminatus Pharma, Inc. Class A Common Stock (LIMN)
EPS as of June 2026 TTM: $-23.70
According to Liminatus Pharma, Inc. Class A Common Stock's latest financial reports, its current EPS (TTM) is $-23.70. At the end of 2025 the company had an EPS of $-21.50, a decrease compared to its 2024 EPS of $-20.00.
EPS history for Liminatus Pharma, Inc. Class A Common Stock from 2021 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-23.70 10.23%
2025 $-21.50 7.50%
2024 $-20.00 166.67%
2023 $-7.50 82.26%
2022 $-4.12 -163.31%
2021 $6.50 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -96.24%
US
$15.66 -166.08%
US
$-7.07 -70.17%
US
$-5.29 -77.68%
AU
$12.73 -153.72%
BE

Questions about Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS)

What is Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS)?

Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) over the last twelve months is $-23.70, as of Jun 2026.

What was Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) in 2025?

In 2025, Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) was $-21.50, compared with $-20.00 in 2024.

How has Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) changed since 2021?

From 2021 to 2025, Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) was highest in 2021 ($6.50) and lowest in 2025 ($-21.50).

How does Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) compare with similar companies?

Liminatus Pharma, Inc. Class A Common Stock's earnings per share (EPS) ($-23.70) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.